Manufacturers

SBM S.A.S

ZI du Monge , 65100 Lourdes
France

Telephone +33 5 62423212
Fax +33 5 62423252
contact@sbm-fr.com

This company is co-exhibitor of
Business France

Trade fair hall

  • Hall 5 / M30
 Interactive Plan

Hall map

MEDICA 2016 hall map (Hall 5): stand M30

Fairground map

MEDICA 2016 fairground map: Hall 5

Our range of products

Product categories

  • 01  Electromedical equipment / Medical Technology
  • 01.03  Therapie and physical medicine
  • 01.03.03  Implants and protheses

Implants and protheses

  • 01  Electromedical equipment / Medical Technology
  • 01.03  Therapie and physical medicine
  • 01.03.03  Implants and protheses
  • 01.03.03.27  Orthopaedic implants and prostheses

Orthopaedic implants and prostheses

About us

Company details

Since 1991, SBM has specialized in the design, manufacturing and marketing of bone repair systems for use in orthopedic surgery, traumatology and neurosurgery.

22 years of experience
SBM is an independent company, founded by Denis CLEMENT, PhD in Biomaterials. Based in Lourdes (Hautes-Pyrénées, France), SBM has a subsidiary in Boston (Massachusetts, USA), SBM Inc.

At the heart of innovation
SBM was not only the first company to introduce Tricalcium Phosphate to perform bone grafts in Europe, but was also the inventor of the first implants for valgus-producing open-wedge tibial osteotomies in 1996.

Today SBM continues to stand out for its unique know-how in the manufacture of biocomposite implants such as Duosorb, allowing the creation of absorbable implants with mechanical resistance, elasticity, and osteoconduction.

An approach of proven quality
Having grown on markets with particularly strict regulations, SBM has developed a demanding ISO 9001-13485 (2000) certified quality management approach, which ensures safety all the way from design to implementation.

Furthermore, SBM was the first European company to be certified for CE marking for its range of synthetic bone augmentation implants (pure Tricalcium Phosphate - Biosorb) in Europe in 1993, and obtained approval from the U.S. FDA (Food and Drug Administration) in 2003.

More Less